稳定胸痛患者冠状动脉CTA的预后价值:PROMISE研究中CAD-RADS、CAC与心血管事件
PROMISE试验中3840例稳定胸痛患者接受冠状动脉CTA,由核心实验室评估CACS、传统狭窄分类和改良CAD-RADS分级(含高危斑块特征),中位随访25个月。CAD-RADS的判别能力(C统计量0.747)显著高于传统狭窄评估(0.698–0.717),且在ASCVD风险评分和CACS基础上提供增量预后价值(C统计量0.776 vs 0.682)。
要点
- CAD-RADS分级对稳定胸痛患者的预后判别能力优于传统狭窄分类。
- CAD-RADS在ASCVD风险评分和CACS基础上提供增量预后价值。
- CAD-RADS 1事件HR为2.43,CAD-RADS 4b和5事件HR为21.84(以CAD-RADS 0为基线)。
核心结论
- 来自大型代表性当代队列的数据支持CAD-RADS作为冠状动脉CTA标准报告系统的预后价值。
研究设计与样本
- PROMISE(前瞻性多中心胸痛评估影像学研究)试验参与者,共3840例 eligible 患者(平均年龄60.4±8.2岁,49%为男性)。
- CTAs由中心CT核心实验室评估CACS、传统狭窄分类和改良CAD-RADS分级(含高危冠状动脉斑块特征)。
- 复合终点为死亡、心肌梗死或因不稳定心绞痛住院,中位随访25个月。
诊断标准与关键数值
- CAD-RADS判别能力C统计量0.747,传统狭窄评估C统计量0.698至0.717,比较均P≤0.001。
- 以无斑块(CAD-RADS 0)为基线,CAD-RADS 1事件HR 2.43(95%CI 1.16至5.08),CAD-RADS 4b和5事件HR 21.84(95%CI 8.63至55.26)。
- CAD-RADS在ASCVD风险评分和CACS基础上增量预后价值C统计量0.776 vs 0.682,P<0.001。
- CAD-RADS的增量价值在所有CACS分层中持续存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of this study was to compare Coronary Artery Disease Reporting and Data System (CAD-RADS) to traditional stenosis categories and the coronary artery calcium score (CACS) for predicting cardiovascular events in patients with stable chest pain and suspected coronary artery disease (CAD).
BACKGROUND: The 2016 CAD-RADS has been established to standardize the reporting of CAD on coronary CT angiography (CTA).
METHODS: PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) trial participants' CTAs were assessed by a central CT core laboratory for CACS, traditional stenosis-based categories, and modified CAD-RADS grade including high-risk coronary plaque (HRP) features. Traditional stenosis categories and CAD-RADS grade were compared for the prediction of the composite endpoint of death, myocardial infarction, or hospitalization for unstable angina over a median follow-up of 25 months. Incremental prognostic value over traditional risk factors and CACS was assessed.
RESULTS: In 3,840 eligible patients (mean age: 60.4 ± 8.2 years; 49% men), 3.0% (115) experienced events. CAD-RADS (concordance statistic [C-statistic] 0.747) had significantly higher discriminatory value than traditional stenosis-based assessments (C-statistic 0.698 to 0.717; all p for comparison ≤0.001). With no plaque (CAD-RADS 0) as the baseline, the hazard ratio (HR) for an event increased from 2.43 (95% confidence interval [CI]: 1.16 to 5.08) for CAD-RADS 1 to 21.84 (95% CI: 8.63 to 55.26) for CAD-RADS 4b and 5. In stepwise nested models, CAD-RADS added incremental prognostic value beyond ASCVD risk score and CACS (C-statistic 0.776 vs. 0.682; p < 0.001), and added incremental value persisted in all CACS strata.
CONCLUSIONS: These data from a large representative contemporary cohort of patients undergoing coronary CTA for stable chest pain support the prognostic value of CAD-RADS as a standard reporting system for coronary CTA.
引用
- Bittner DO, Mayrhofer T, Budoff M, et al. Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISE. JACC Cardiovasc Imaging. 2019. PMID: 31734213. doi:10.1016/j.jcmg.2019.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。